Key points from article :
SENISCA is a start-up company aiming to develop “senotherapeutic interventions”.
Found a new molecular pathway to create a new generation of senotherapeutic drugs.
Works by switching off the genes that control RNA splicing factors.
This turns on RNA splicing regulation to bring cells out of senescence and rejuvenates them.
Focused on tropical treatments for skin ageing and treatment for target diseases.
University of Exeter spinout SENISCA is currently raising a seed round of £950,000.